Connor, Clark & Lunn Investment Management (CC&L)
LUNG icon

Connor, Clark & Lunn Investment Management (CC&L)’s Pulmonx LUNG Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,237
Closed -$32.8K – 1681
2025
Q3 		$32.8K Sell
20,237
-198,521
-91% -$415K ﹤0.01% 1472
2025
Q2 		$567K Buy
218,758
+53,148
+32% +$210K ﹤0.01% 1215
2025
Q1 		$1.11M Buy
165,610
+81,669
+97% +$578K ﹤0.01% 916
2024
Q4 		$570K Buy
83,941
+25,988
+45% +$171K ﹤0.01% 1109
2024
Q3 		$480K Buy
+57,953
New +$419K ﹤0.01% 1107

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s LUNG Position: Q4 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Pulmonx (LUNG) in Q4 2025, closing a stake of 20,237 shares — an estimated $32.8K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in LUNG in Q3 2024 and held it in 5 quarters. The position peaked at $1.11M in Q1 2025. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Pulmonx position as of Q4 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 20,237 Pulmonx shares in Q4 2025, an estimated $32.8K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Pulmonx in Q3 2024 and held it in 5 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Pulmonx position peaked at $1.11M in Q1 2025.
  • 112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2025, filed 10 Feb 2026.